References
- HariprasadSMAkdumanLCleverJAOberMRecchiaFMMielerWFTreatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%Clin Ophthalmol2009314715419668559
- ChalamKVKeshavamurthyRBrarVSSpectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusionEur J Ophthalmol20081883183318850569
- KorenfeldMSSilversteinSMCookeDLVogelRCrockettRSDifluprednate Ophthalmic Emulsion 0.05% (Durezol) Study GroupDifluprednate ophthalmic emulsion 0.05% for postoperative inflammation and painJ Cataract Refract Surg200935263419101421
- FosterCSDavanzoRFlynnTEDurezol (difluprednate ophthalmic emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitisJ Ocul Pharmacol Ther2010247548320809807
- TajikaTWakiMTsuzukiMKidaTSakakiHPharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassayJ Ocul Pharmacol Ther201127293421182429
- NakanoSYamamotoTKiriiEAbeSYamashitaHSteroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edemaGraefes Arch Clin Exp Ophthalmol201024880581020180131
- ShelstaHNJampolLMPharmacologic therapy of pseudophakic cystoid macular edema: 2010 updateRetina20113141221187730
- FlachAJThe incidence, pathogenesis and treatment of cystoid macular edema following cataract surgeryTrans Am Ophthalmol Soc19989655763410360304
- SpitzerMSZiemssenFYoeruekEEfficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edemaJ Cataract Refract Surg200834707518165084
- AhmadabadiHFMohammadiMBeheshtnejadHMirshahiAEffect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsificationJ Cataract Refract Surg20103691792220494761